Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 2,700

• Price / Volume Information    Yesterday's Closing Price: $45.43 Daily Weekly Monthly 20 Day Moving Average: 156,801 shares Shares Outstanding: 16.44 (millions) Market Capitalization: $746.70 (millions) Beta: 0.42 52 Week High: $48.52 52 Week Low: $4.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 14.84% 9.74% 12 Week 123.57% 90.96% Year To Date 207.38% 187.91%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@multiplan.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer and Director Douglas M. Garis - Executive Vice President and Chief Financial Offic Gerald J. Kozel - Senior Vice President and Chief Accounting Officer Allen R. Thorpe - Lead Independent Director Richard A. Clarke - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/07/25 Share - Related Items Shares Outstanding: 16.44 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.42 Market Capitalization: $746.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-11.25 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/07/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 50.37 Price/Cash Flow: 2.53 Price / Sales: 0.81 EPS Growth vs. Year Ago Period: -185.83% vs. Previous Quarter: 33.27% Sales Growth vs. Year Ago Period: -1.36% vs. Previous Quarter: -0.35% ROE 06/30/25 - - 03/31/25 - -84.47 12/31/24 - -30.40 ROA 06/30/25 - - 03/31/25 - -3.61 12/31/24 - -2.78 Current Ratio 06/30/25 - - 03/31/25 - 1.02 12/31/24 - 0.82 Quick Ratio 06/30/25 - - 03/31/25 - 1.02 12/31/24 - 0.82 Operating Margin 06/30/25 - - 03/31/25 - -20.72 12/31/24 - -16.87 Net Margin 06/30/25 - - 03/31/25 - -126.96 12/31/24 - -176.85 Pre-Tax Margin 06/30/25 - - 03/31/25 - -140.05 12/31/24 - -190.27 Book Value 06/30/25 - - 03/31/25 - 0.90 12/31/24 - 5.19 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 310.26 12/31/24 - 53.67 Debt-to-Capital 06/30/25 - - 03/31/25 - 99.68 12/31/24 - 98.17

Powered by Zacks Investment Research ©